Dr. David Y. Liu has over 23 years of Biotechnology industry experience in addition to 10 years of postgraduate academic research. Most recently he has spent more than 7 years at FibroGen Inc as Vice President of Research,
Scientific Advisor/Founder of Sphaera Pharma and Ferguson Distinguished Professor and Associate Dean, Research and Graduate Education, School of Pharmacy, The University of North Carolina at Chapel Hill.
Dr. Mendenhall has over 35 years of experience in the pharmaceutical industry. Most recently he was VP of Worldwide Pharmaceutical R&D at Merck from 2001-2008. During that time he also served as Basic Research Site Head of their West Point facility in 2007-08.
Dr. Pandey is Professor and a Distinguished Member of Cellular Stress Biology, and also a Research Professor at the Institute of Lasers, Photonics and Biophotonics SUNY, Buffalo and the Roswell Park Cancer Institute.
Prof. Ronald T. Borchardt is the Solon E. Summerfield Distinguished Professor of Pharmaceutical Chemistry at The University of Kansas-Lawrence. He has been involved in drug design and development for over 30 years.
Dr. Badley received his M.D. degree from Dalhousie University in Halifax, Nova Scotia in 1990. He did residency and Clinician Investigator Training in Infectious Diseases at Mayo Clinic, Rochester Minnesota, graduating in 1997.
Sphaera Pharma is an integrated drug discovery and development organization led by pharma and biotech professionals with global experience. Our goal is to bring innovative therapies to patients with unmet medical needs by developing a balanced portfolio of early stage discovery projects and clinical programs.